title: Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study.
abstract: Managing a CNS neoplasm during pregnancy presents complex challenges, and population-based studies are lacking. We designed a retrospective cohort study using the Nationwide Inpatient Sample (NIS) to investigate pregnancy outcomes in women with CNS neoplasms. We constructed a logistic regression model for maternal mortality, preterm labor, intrauterine growth restriction (IUGR), and Caesarean delivery, controlling for age, comorbidities, and demographic characteristics. We identified 379 malignant brain tumors, 437 benign brain tumors, and 44 spine tumors among 19 million pregnancy-related admissions from 1988 through 2009. Malignant brain tumors were associated with maternal mortality (odds ratio [OR], 143), preterm labor (OR, 3.4), and IUGR (OR, 2.9). Benign brain tumors were associated with preterm labor (OR, 2.3). A diagnosis of hyperemesis gravidarum was more common in malignant (OR, 2.2) and benign (OR, 2.8) brain tumors. Compared with the general population, Caesarean delivery was more frequent for malignant (OR, 6.4) and benign (OR, 2.8) brain tumors and spine tumors (OR, 3.9). Admission without delivery was more common for malignant (OR, 8.6) and benign (OR, 4.3) brain tumors and spine tumors (OR, 3.8; P < .05 for all outcomes). Thirty-three percent of all hospitalizations involved neurosurgical procedures, but pregnancy complications were not significantly more likely to occur in surgical patients. In conclusion, malignant brain tumors were associated with adverse pregnancy outcomes, and CNS neoplasms were associated with higher rates of Caesarean delivery. Additional research is needed to improve understanding of obstetric risk in these patients and to assist with treatment, counseling, and monitoring during delivery.
authors.affiliation: Neurosurgical Service, White 502, Massachusetts General Hospital, Boston, MA 02114, USA. arterry1977@gmail.com
authors.forename: Anna R
authors.initials: AR
authors.lastname: Terry
authors.forename: Fred G
authors.initials: FG
authors.lastname: Barker
authors.forename: Lisa
authors.initials: L
authors.lastname: Leffert
authors.forename: Brian T
authors.initials: BT
authors.lastname: Bateman
authors.forename: Irene
authors.initials: I
authors.lastname: Souter
authors.forename: Scott R
authors.initials: SR
authors.lastname: Plotkin
mesh_terms: D000293:Adolescent; D000328:Adult; D001900:Boston / Q000453:epidemiology; D001932:Brain Neoplasms / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D002585:Cesarean Section; D002648:Child; D036861:Delivery, Obstetric; D005260:Female; D005317:Fetal Growth Retardation; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D008428:Maternal Mortality; D007752:Obstetric Labor, Premature; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000453:epidemiology / Q000209:etiology*; D011256:Pregnancy Outcome; D012189:Retrospective Studies; D012307:Risk Factors; D013125:Spinal Neoplasms / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D015996:Survival Rate; D055815:Young Adult